Mesothelioma Lawsuit Against Talcum Powder Manufacturers Ends In $12M Verdict

A California jury awarded $12 million in damages this week to a woman who alleged that she was diagnosed with mesothelioma due to exposure to talcum powder products contaminated with asbestos, including Johnson’s Baby Powder, Shower-to-Shower and Colgate’s Cashmere Bouquet.

The verdict was returned in a mesothelioma lawsuit filed by Patricia Schmitz, who indicated that she was diagnosed with the rare form of cancer following years of using talcum powder products.

The Alameda County Superior Court jury indicated that Johnson & Johnson and Colgate should each pay Schmitz $4.8 million in compensatory damages. In addition, Avon Products was deemed responsible for $2.4 million in damages, but the company was not named as a defendant in the lawsuit, so it is unlikely she will recover that portion of the award. The jury could not agree on whether to award additional punitive damages, which would have been designed to punish the manufacturers for recklessly disregarding the health of consumers.

Learn More About

Talcum Powder Lawsuits

Talcum powder or talc powder may cause women to develop ovarian cancer.

Learn More See If You Qualify For Compensation

Johnson & Johnson currently faces nearly 12,000 Johnson’s Baby Powder lawsuits and Shower-to-Shower lawsuits pending in courts nationwide, each raising similar claims that the manufacturer has known for decades that their products may contain asbestos and increase the risk of cancer, yet failed to warn consumers.

In addition to mesothelioma lawsuits, many of the complaints involve allegations that particles included in the talcum powder may cause ovarian cancer, following years of regular application around the genitals for feminine hygiene.

A number of cases have already gone to trial at the state level, with several resulting in large verdicts for plaintiffs, often including punitive damages. Last year, a Missouri jury returned a landmark $4.7 billion verdict for 22 women diagnosed with ovarian cancer.

Johnson & Johnson has indicated it will appeal this latest verdict.

This is not the first loss for Colgate either. In April 2016, Colgate-Palmolive was ordered to pay $1.4 million to a woman diagnosed with mesothelioma after exposure to Cashmere Bouquet talc powder. Colgate-Palmolive reached an undisclosed settlement in November 2017 over another talcum powder asbestos claim.

Most of the talcum powder litigation is current pending in the federal court system, where lawsuits filed by individuals nationwide are centralized for pretrial proceedings as part of a multidistrict litigation (MDL), which is centralized before U.S. District Judge Freda L. Wolfson in the District of New Jersey.

Later this year, Judge Wolfson is expected to rule on Johnson & Johnson’s challenges to the admissibility of certain expert witness testimony under the federal rules. However, if the Court finds that the evidence is sufficiently reliable, Johnson & Johnson could face large numbers of individual trial dates in courts nationwide in coming years.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted today)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.

Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters
Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters (Posted today)

A recent report suggests that Johnson & Johnson is offering an additional $1.1 billion to settle talcum powder lawsuits, as part of a proposed $9 billion deal that would resolve all ovarian cancer claims as part of a third bankruptcy filing by the manufacturer.

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 3 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.